SlideShare una empresa de Scribd logo
1 de 46
International Projects to
Prevent Chronic Wounds
    Professor Carol Dealey
In this presentation
• I will be talking about 3 different international
  projects in which I have been involved as useful
  examples

• They have all been undertaken in a slightly
  different way

• They all involve pressure ulcers
International Pressure Ulcer
            Guidelines
• This project took over my life for 5 years!

• It was very hard work, but very satisfying.

• I made some good friends during this time

• So – here is the story of how the guidelines were
  developed.
The Two Societies
                                                     .
EPUAP = European Pressure Ulcer      NPUAP = National Pressure Ulcer
Advisory Panel, founded in 1996 it   Advisory Panel and it is an
is a Pan-European Society            American society founded in 1987
• Both associations had produced pressure ulcer
  guidelines:
   NPUAP in 1992 (Prevention) and 1994
    (Treatment)
   EPUAP in 1997 (Prevention, 1998 (Treatment)
    and 2003 (Nutrition)

  There was an urgent need for these
  guidelines to be updated
When in doubt – form a committee!

• Guideline development
  Group (GDG)– from both
  EPUAP and NPUAP
• Carol Dealey – Chair
  EPUAP GDG
• Janet Cuddigan & Diane
  Langemo – Co-Chairs of
  NPUAP GDG
• 5 members from each
  society
Guideline Development Group

 European Pressure Ulcer Advisory Panel
             Dr. Carol Dealey
            Dr. Michael Clark,
        Dr. Lisette Schoonhoven,
             Anne Witherow,
          Prof. Dr. Tom Defloor,
         Dr. Katrien Vanderwee

        National Pressure Ulcer
            Advisory Panel
           Dr. Janet Cuddigan
         Dr. Diane K. Langemo
        Dr. Mona M. Baharestani
         Mary Ellen Posthauer
             Dr. Joyce Black
                Evan Call
•   The full GDG (NPUAP and EPUAP) defined a
    search strategy for both guidelines.
•   Evidence was limited to papers published in
    peer-reviewed journals and cited on PubMed,
    CINAHL, EMBASE, AHMED or the Cochrane
    and HTA databases. Quantitative studies were
    included if they were laboratory-based studies,
    controlled or cohort studies.
•   The full GDG developed a template for all the
    evidence tables
• The full GDG agreed the hierarchy of evidence
  to be used in both guidelines
• Each guideline was divided into a series of
  topics, recognising that there will be some
  overlap between the two.
• The treatment guideline does not include all
  possible topics, but has assessed those most
  clinically useful
Strength of Evidence Rating for
      Strength of Evidence
        Recommendations
• A – Recommendation supported by direct scientific
  evidence from properly designed & implemented controlled
  trials on PU in humans providing statistical results that
  consistently support the guideline statement. (Level I
  studies)
• B – Recommendation supported by direct scientific
  evidence from properly designed & implemented clinical
  series on PU in humans providing statistical results that
  consistently support the recommendation. (Level II, III, IV, V
  studies)
• C – The recommendation is supported by expert opinion or
  indirect evidence (e.g. surrogate outcomes, studies in
  animal models & other types of chronic wounds).
Reviewing the Evidence

Small Working Groups (SWGs)

• Sub-groups, each with a sub-group leader,
  reviewed the literature for specific topics
• Evidence tables were produced, allowing the
  SWG to develop guideline statements and a
  summary of the evidence
• Guideline statements and supporting text sent to
  GDG for review
•   Draft recommendations then circulated to full
    GDG (NPUAP and EPUAP) for comments

•   The GDG met to agree format for the guideline
    document and review the draft
    recommendations in order to develop the 1st
    draft of the guideline topics

•   The topics were then made available for
    stakeholder review
146 Representatives from 32
        Countries
And 903 individuals from 53
         countries
Review
• Every stakeholder was informed when the
  statements were available for review and given
  the opportunity to comment on the statements
  both by suggesting literature that might have
  been missed and commenting on the text
• The full GDG met to discuss each comment and
  review the suggested literature
• The guideline text was then revised in the
  light of the literature/comments as
  appropriate
Final Draft Stage
• This stage was all about
  ensuring there were no
  anomalies between
  treatment and prevention
• Checking the text for
  typos
• Ensuring we had all the
  evidence tables
• Checking and rechecking
  the references
The Guidelines were
published in 2009
They are available as a
Clinical Practice Guide
and as Quick Reference
Guides

The QRG is available in
18 different languages
including Portuguese

The translations are
freely available for
download at
www.epuap.org
What did I learn about International
              collaboration?
• It is really important to talk to
  each other – emails are not
  enough!
• When we started the
  guidelines the 2 societies did
  not know each other well and
  there were misunderstandings
  at first. American English and
  English English are not the
  same!
• Be prepared to compromise
THE NEXT EXAMPLE
A project to produce a
consensus document on
pressure ulcer aetiology.
It aimed to expand on the
information in the
International Pressure
Ulcer Guidelines.
Unlike the Guidelines
which were funded by
EPUAP and NPUAP, this
was funded by an
unrestricted educational
grant from KCI Europe
Holding BV
Expert working group
•   Mona Baharestani*, (USA)       •   Maarten Lubbers*, (The
•                                      Netherlands)
    Joyce Black*, (USA)
                                   •   Courtney Lyder*, (USA)
•   Keryln Carville, (Australia)
                                   •   Takehiko Ohura, (Japan)
•   Michael Clark*, (UK)
                                   •   Heather Orsted, (Canada)
•   Janet Cuddigan*, (USA)
                                   •   Vinoth Ranganathan, (USA)
•   Carol Dealey*, (UK)
                                   •   Steven Reger*, (USA)
•   Tom Defloor*, (Belgium)
                                   •   Marco Romanelli*, (Italy)
•   Amit Gefen*, (Israel)
                                   •   Hiromi Sanada, (Japan)
•   Keith Harding, (UK)
                                   •   Makoto Takahashi, (Japan)
•   Nils Lahmann*, Berlin
    (Germany)
    * = worked on EPUAP/NPUAP Guidelines
Pressure, shear, friction and
     microclimate – why needed?
• Pressure has long been viewed as the most
  important extrinsic factor in pressure ulcer
  development
• Increasing interest in the roles of shear, friction
  and microclimate
• Emerging awareness of the synergistic links
  between pressure, shear, friction and
  microclimate
Pressure, shear, friction and
            microclimate
Groundbreaking initiative:
• Fulfilled a need for educational materials that aid
  understanding of the basic physics involved in
  pressure, shear, friction and microclimate

• Demonstrated how the physics involved
  underpins best clinical practice in the prevention
  (and treatment) of pressure ulcers
Pressure, shear, friction and
            microclimate
The technical section of each paper:

• Defined the relevant extrinsic factor
• Clearly described basic physics involved
• Explained the contribution of the extrinsic factor
  to pressure ulcer aetiology
• Described the links between the factors
Pressure, shear, friction and
             microclimate
The clinical practice section of each paper:
• Described how to identify patients at risk from the
  extrinsic factor
• Explained the types of and rationale for the clinical
  interventions that aim to prevent or ameliorate the
  effects of the extrinsic factor

Note: Pressure ulcer prevention involves much more than
  extrinsic factor modification: this document was not
  intended to provide a comprehensive discussion of
  pressure ulcer prevention protocols
How did this project work?
• This work was undertaken
  with a mixture of
  teleconferences and emails
• The scientists wrote the
  physics part and some of
  the clinicians (mostly
  nurses) wrote the clinical
  application
• It went out for review to the
  rest of the expert group
The Outcome
A useful document
freely available to
download from the
Wounds International
website:
http://www.woundsinte
rnational.com/pdf/cont
ent_8925.pdf
What did I learn from this project?

• We need scientists to explain the
  physics

• But they cannot apply this
  knowledge to clinical practice –
  that is where nurses come in.

• So we need multi-professional
  working – and to respect each
  others’ expertise
There’s more
• When you know each
  other it is easier to
  work at long distance
• This project involved
  writing, reviewing and
  judicious editing and
  formatting (by Wounds
  International)
• There did not need to
  be a lot of debate on
  the content
MY LATEST PROJECT
Global Evidence Based
Practice Recommendations
for the Use of Wound
Dressings to Augment
Pressure Ulcer Prevention
Protocols - August 2012
This is very new and not
totally completed, so I am
going to tell you quite a bit
about it
It has been funded by an
educational grant from
Molnlycke Healthcare
Consensus group

Joyce Black RN PhD                      Michael Clark PhD                       Paulo Alves RN MSc                         Tod Brindle RN MSc
(Co-Chair)                              (Co-Chair)                              Paulo Alves is an Assistant Professor      Tod Brindle is a wound and ostomy
Dr Black is an Associate Professor of   Dr Clark is a Visiting Professor in     of Nursing and Tissue Viability at the     consultant for the Virginia
Nursing at the University of Nebraska   Tissue Viability, Birmingham City       Catholic University of Portugal and        Commonweath University Medical
in the USA. She is a Fellow of the US   University, UK and Manager of the       researcher of the Portuguese Wound         Center, Richmond, in the USA. His
Academy of Nursing and currently on     Welsh Wound Network. He is also         Management Association. Pressure           clinical specialty area includes
the Board of the National Pressure      President of the European Pressure      Ulcers are his main research. He is        pressure ulcer prevention in high risk
Ulcer Advisory Panel.                   Ulcer Advisory Panel                    currently a board member of the            populations.
                                                                                European Pressure Ulcer Advisory
                                                                                Panel and the European Wound
                                                                                Management Association.




Evan Call MS, CSM (NRM)                 Carol Dealey RN PhD                     Nick Santamaria RN PhD
Evan Call is Adjunct Faculty in the     Dr Dealey is Senior Research Fellow     Dr Santamaria is Professor of
Microbiology Department at Weber        at University Hospital Birmingham       Nursing Research, Translational
State University, USA, and              NHS Foundation Trust and Honorary       Research at The University of
undertakes research in relation to      Professor in Tissue Viability at        Melbourne and The Royal Melbourne
medical devices for pressure ulcer      University of Birmingham in the UK.     Hospital, Australia. His research
prevention. He is currently on the      Her main research programme is the      involves the prevention of pressure
Board of the National Pressure Ulcer    prevention of pressure ulcers. She is   ulcers in critically ill trauma patients
Advisory Panel.                         a Past President of the European        in ICU.
                                        Pressure Ulcer Advisory Panel.
What have we been doing?
1. A literature review of current evidence which included both clinical
   and laboratory studies relating to the use of dressings for pressure
   ulcer prevention
2. This improved our understanding of their role in reducing the
   impact of pressure, shear and microclimate
3. This information provided the evidence we needed to develop Best
   Practice Statements of the likely effectiveness of dressing when
   used in pressure ulcer prevention alongside other prevention
   methods. These statements were presented at the WUWHS
   Conference in Japan in a Quick Reference Guide
4. We are planning a full document with all the evidence to be
   submitted for publication in a wound journal
• So what do dressings
   do in pressure ulcer
       prevention?
Shear redistribution




                     The dressing translates shear force to
                     the skin outside the area of concern.
Without a dressing   Within the dressing the interface of
                     multiple layers aids in the absorption of
                     shear
Friction reduction




                     If the surface of the dressing is slippery
Without a dressing   it will reduce friction, conversely if it is
                     not it will increase friction.
Pressure

• redistribution




    Without a dressing      A dressing with adequate thickness distributes
                            forces over a larger area thus accomplishing
                            pressure re-distribution
Balance of Skin Microclimate




With a basic dressing   With a multi layer silicone foam dressing
Balance of Microclimate
A dressing that maintains relative humidity of
between 40 and 80% at the skin surface helps
maximise the resilience of the skin.
Dressings that trap moisture at the skin surface
reduce the strength of the skin and lead to
maceration.
Dressings that withdraw too much moisture can
predispose skin to stiffness and cracking.
This can be identified by obvious signs of
maceration or dryness.
Do some dressings outperform others?

• Laboratory tests
  found a multilayer
  silicone dressing out-
  performed others
• But need clinical
  confirmation – there
  are some cohort
  studies + awaiting the
  results of an
  Australian RCT
In the meantime….


Based on what we
know so far we
have produced a
dressing selection
guide
Part of the Dressing Selection Guide for Pressure
   Ulcer Prevention in the Sacrum and Buttocks

Mechanism of Injury            Mechanisms of                   Dressing Selection
Pressure, Friction,            Protection
Shear & Microclimate
Elevating the head of the      The dressings used for          Structure:
bed increases pressure and     pressure ulcer prevention
shear on the pelvic region,    should:                         A multi layer silicone foam
note the percent of body       1. Redistribute pressure        dressing
mass that is focused on the    2. Minimise shear               with the ability to redistribute
pelvic region as the head of   3. Balance micro-climate        pressure, redistribute and
bed is raised.                 4. Reduce friction              absorb shear, and
0° = 30% of body mass          5. Prevent mechanical           effectively manage
30° = 44% of body mass         stripping of skin when          microclimate.
45° = 52% of body mass         removing the dressing to
90° = 70% of body mass         inspect the skin
                               6. Provide barrier protection
                               to the skin
                               7. Have an atraumatic
                               contact layer
You can get a copy




From the Neve
Stand in the
Exhibition
So what have I learnt from this project?


• We had an initial meeting followed by
  teleconferences. This worked when we were
  assembling the evidence.
• It did not work for writing the Best Practice
  Statements and we ended up meeting for 2 days
  to write them
• Meetings are essential for writing guidelines or
  best practice statements
Overall Conclusions
• It is good to work with colleagues from other
  countries – people are the same everywhere, we
  just need to get better at talking to each other

• Nurses can make an important contribution – but
  we need to work in multi-professional groups in
  order to produce really significant outcomes
Any Questions?

Más contenido relacionado

Similar a International Projects Prevent Chronic Wounds

1, 2. Research proposal & Res. Article.pptx
1, 2. Research proposal & Res. Article.pptx1, 2. Research proposal & Res. Article.pptx
1, 2. Research proposal & Res. Article.pptxMansoorAhmed57263
 
Satisfying the Evolving Role of Physiotherapists in Knowledge Translation Usi...
Satisfying the Evolving Role of Physiotherapists in Knowledge Translation Usi...Satisfying the Evolving Role of Physiotherapists in Knowledge Translation Usi...
Satisfying the Evolving Role of Physiotherapists in Knowledge Translation Usi...Physiopedia
 
Katie L. Hamm Resume
Katie L. Hamm ResumeKatie L. Hamm Resume
Katie L. Hamm ResumeKatie Hamm
 
EMPHNET-PHE Course: Module seven ethical issues in public health research& in...
EMPHNET-PHE Course: Module seven ethical issues in public health research& in...EMPHNET-PHE Course: Module seven ethical issues in public health research& in...
EMPHNET-PHE Course: Module seven ethical issues in public health research& in...Dr Ghaiath Hussein
 
Evidence Aid: who and why
Evidence Aid: who and whyEvidence Aid: who and why
Evidence Aid: who and whyALNAP
 
Systematic reviews and trials (Claire Allen, Evidence Aid)
Systematic reviews and trials (Claire Allen, Evidence Aid)Systematic reviews and trials (Claire Allen, Evidence Aid)
Systematic reviews and trials (Claire Allen, Evidence Aid)ALNAP
 
Lecture 1 Introduction to Nx Research (1)(1).pptx
Lecture 1 Introduction to Nx Research (1)(1).pptxLecture 1 Introduction to Nx Research (1)(1).pptx
Lecture 1 Introduction to Nx Research (1)(1).pptxAbdallahAlasal1
 
Implementing Patient & Public Involvement in Research: 27.06.2017
Implementing Patient & Public Involvement in Research: 27.06.2017Implementing Patient & Public Involvement in Research: 27.06.2017
Implementing Patient & Public Involvement in Research: 27.06.2017RDSLondon
 
Trimble 12 12-11
Trimble 12 12-11Trimble 12 12-11
Trimble 12 12-11EUintheUS
 
REG IPF / ILD Working Group Meeting
REG IPF / ILD Working Group MeetingREG IPF / ILD Working Group Meeting
REG IPF / ILD Working Group MeetingZoe Mitchell
 
Randomized Controlled Trials
Randomized Controlled TrialsRandomized Controlled Trials
Randomized Controlled TrialsNabeela Basha
 
2022_04_25_ESCNH_Overview.pptx.ppt
2022_04_25_ESCNH_Overview.pptx.ppt2022_04_25_ESCNH_Overview.pptx.ppt
2022_04_25_ESCNH_Overview.pptx.pptpashblessings
 
Checklists, Never Events, and Lifebox Foundation
Checklists, Never Events, and Lifebox FoundationChecklists, Never Events, and Lifebox Foundation
Checklists, Never Events, and Lifebox FoundationDr Edward Fitzgerald
 

Similar a International Projects Prevent Chronic Wounds (20)

1, 2. Research proposal & Res. Article.pptx
1, 2. Research proposal & Res. Article.pptx1, 2. Research proposal & Res. Article.pptx
1, 2. Research proposal & Res. Article.pptx
 
Satisfying the Evolving Role of Physiotherapists in Knowledge Translation Usi...
Satisfying the Evolving Role of Physiotherapists in Knowledge Translation Usi...Satisfying the Evolving Role of Physiotherapists in Knowledge Translation Usi...
Satisfying the Evolving Role of Physiotherapists in Knowledge Translation Usi...
 
How to write an abstract
How to write an abstractHow to write an abstract
How to write an abstract
 
Driving progress in healthcare through NHS research
Driving progress in healthcare through NHS researchDriving progress in healthcare through NHS research
Driving progress in healthcare through NHS research
 
Declaration of Helsinki
Declaration of HelsinkiDeclaration of Helsinki
Declaration of Helsinki
 
Katie L. Hamm Resume
Katie L. Hamm ResumeKatie L. Hamm Resume
Katie L. Hamm Resume
 
PUBLISHING ARTICLES
PUBLISHING ARTICLESPUBLISHING ARTICLES
PUBLISHING ARTICLES
 
EMPHNET-PHE Course: Module seven ethical issues in public health research& in...
EMPHNET-PHE Course: Module seven ethical issues in public health research& in...EMPHNET-PHE Course: Module seven ethical issues in public health research& in...
EMPHNET-PHE Course: Module seven ethical issues in public health research& in...
 
Evidence Aid: who and why
Evidence Aid: who and whyEvidence Aid: who and why
Evidence Aid: who and why
 
Systematic reviews and trials (Claire Allen, Evidence Aid)
Systematic reviews and trials (Claire Allen, Evidence Aid)Systematic reviews and trials (Claire Allen, Evidence Aid)
Systematic reviews and trials (Claire Allen, Evidence Aid)
 
Introduction to EBP
Introduction to EBPIntroduction to EBP
Introduction to EBP
 
Lecture 1 Introduction to Nx Research (1)(1).pptx
Lecture 1 Introduction to Nx Research (1)(1).pptxLecture 1 Introduction to Nx Research (1)(1).pptx
Lecture 1 Introduction to Nx Research (1)(1).pptx
 
INITIATING RESEARCH AT UNDER GRADUATE LEVEL: A PARADIGM SHIFT
INITIATING RESEARCH AT UNDER GRADUATE LEVEL: A PARADIGM SHIFTINITIATING RESEARCH AT UNDER GRADUATE LEVEL: A PARADIGM SHIFT
INITIATING RESEARCH AT UNDER GRADUATE LEVEL: A PARADIGM SHIFT
 
Implementing Patient & Public Involvement in Research: 27.06.2017
Implementing Patient & Public Involvement in Research: 27.06.2017Implementing Patient & Public Involvement in Research: 27.06.2017
Implementing Patient & Public Involvement in Research: 27.06.2017
 
Declaration of helsinki (Pharmacology SEM-III)
Declaration of helsinki (Pharmacology SEM-III)Declaration of helsinki (Pharmacology SEM-III)
Declaration of helsinki (Pharmacology SEM-III)
 
Trimble 12 12-11
Trimble 12 12-11Trimble 12 12-11
Trimble 12 12-11
 
REG IPF / ILD Working Group Meeting
REG IPF / ILD Working Group MeetingREG IPF / ILD Working Group Meeting
REG IPF / ILD Working Group Meeting
 
Randomized Controlled Trials
Randomized Controlled TrialsRandomized Controlled Trials
Randomized Controlled Trials
 
2022_04_25_ESCNH_Overview.pptx.ppt
2022_04_25_ESCNH_Overview.pptx.ppt2022_04_25_ESCNH_Overview.pptx.ppt
2022_04_25_ESCNH_Overview.pptx.ppt
 
Checklists, Never Events, and Lifebox Foundation
Checklists, Never Events, and Lifebox FoundationChecklists, Never Events, and Lifebox Foundation
Checklists, Never Events, and Lifebox Foundation
 

Más de Anais IV CBED

Programa Final - IV CBED
Programa Final - IV CBEDPrograma Final - IV CBED
Programa Final - IV CBEDAnais IV CBED
 
Premiação dos Melhores Trabalhos
Premiação dos Melhores TrabalhosPremiação dos Melhores Trabalhos
Premiação dos Melhores TrabalhosAnais IV CBED
 
Nadia - A universidade (19/09/2012 - Manhã)
Nadia - A universidade (19/09/2012 - Manhã)Nadia - A universidade (19/09/2012 - Manhã)
Nadia - A universidade (19/09/2012 - Manhã)Anais IV CBED
 
Dra. Shirlei - Sobende (19/09/2012 - Manhã)
Dra. Shirlei - Sobende (19/09/2012 - Manhã)Dra. Shirlei - Sobende (19/09/2012 - Manhã)
Dra. Shirlei - Sobende (19/09/2012 - Manhã)Anais IV CBED
 
Dr. Neuranides - Atuação dos órgãos reguladores da profissão (19/09/2012 - Ma...
Dr. Neuranides - Atuação dos órgãos reguladores da profissão (19/09/2012 - Ma...Dr. Neuranides - Atuação dos órgãos reguladores da profissão (19/09/2012 - Ma...
Dr. Neuranides - Atuação dos órgãos reguladores da profissão (19/09/2012 - Ma...Anais IV CBED
 
Apresentação Oral - Trabalho 41 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 41 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 41 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 41 (19/09/2012 - Tarde)Anais IV CBED
 
Apresentação Oral - Trabalho 42 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 42 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 42 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 42 (19/09/2012 - Tarde)Anais IV CBED
 
Apresentação Oral - Trabalho 44 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 44 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 44 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 44 (19/09/2012 - Tarde)Anais IV CBED
 
Apresentação Oral - Trabalho 45 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 45 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 45 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 45 (19/09/2012 - Tarde)Anais IV CBED
 
Apresentação Oral - Trabalho 46 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 46 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 46 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 46 (19/09/2012 - Tarde)Anais IV CBED
 
Apresentação Oral - Trabalho 88 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 88 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 88 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 88 (19/09/2012 - Tarde)Anais IV CBED
 
Curso enfermagem dermato.pediat. - 20/09/2012
Curso enfermagem dermato.pediat. - 20/09/2012Curso enfermagem dermato.pediat. - 20/09/2012
Curso enfermagem dermato.pediat. - 20/09/2012Anais IV CBED
 
Dra. lina - 20/09/2012
Dra. lina - 20/09/2012Dra. lina - 20/09/2012
Dra. lina - 20/09/2012Anais IV CBED
 
Dra. sandra gargur - 20/09/2012
Dra. sandra gargur - 20/09/2012Dra. sandra gargur - 20/09/2012
Dra. sandra gargur - 20/09/2012Anais IV CBED
 
Dra. silvana ferreira - 20/09/2012
Dra. silvana ferreira - 20/09/2012Dra. silvana ferreira - 20/09/2012
Dra. silvana ferreira - 20/09/2012Anais IV CBED
 
Dra. vania declair - 20/09/2012
Dra. vania declair - 20/09/2012Dra. vania declair - 20/09/2012
Dra. vania declair - 20/09/2012Anais IV CBED
 
Pedro dantas - 20/09/2012
Pedro dantas - 20/09/2012Pedro dantas - 20/09/2012
Pedro dantas - 20/09/2012Anais IV CBED
 
Quality care indicators - 20/09/2012
Quality care indicators - 20/09/2012Quality care indicators - 20/09/2012
Quality care indicators - 20/09/2012Anais IV CBED
 
Shirley - 20/09/2012
Shirley - 20/09/2012Shirley - 20/09/2012
Shirley - 20/09/2012Anais IV CBED
 

Más de Anais IV CBED (20)

Anais IV CBED
Anais IV CBEDAnais IV CBED
Anais IV CBED
 
Programa Final - IV CBED
Programa Final - IV CBEDPrograma Final - IV CBED
Programa Final - IV CBED
 
Premiação dos Melhores Trabalhos
Premiação dos Melhores TrabalhosPremiação dos Melhores Trabalhos
Premiação dos Melhores Trabalhos
 
Nadia - A universidade (19/09/2012 - Manhã)
Nadia - A universidade (19/09/2012 - Manhã)Nadia - A universidade (19/09/2012 - Manhã)
Nadia - A universidade (19/09/2012 - Manhã)
 
Dra. Shirlei - Sobende (19/09/2012 - Manhã)
Dra. Shirlei - Sobende (19/09/2012 - Manhã)Dra. Shirlei - Sobende (19/09/2012 - Manhã)
Dra. Shirlei - Sobende (19/09/2012 - Manhã)
 
Dr. Neuranides - Atuação dos órgãos reguladores da profissão (19/09/2012 - Ma...
Dr. Neuranides - Atuação dos órgãos reguladores da profissão (19/09/2012 - Ma...Dr. Neuranides - Atuação dos órgãos reguladores da profissão (19/09/2012 - Ma...
Dr. Neuranides - Atuação dos órgãos reguladores da profissão (19/09/2012 - Ma...
 
Apresentação Oral - Trabalho 41 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 41 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 41 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 41 (19/09/2012 - Tarde)
 
Apresentação Oral - Trabalho 42 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 42 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 42 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 42 (19/09/2012 - Tarde)
 
Apresentação Oral - Trabalho 44 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 44 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 44 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 44 (19/09/2012 - Tarde)
 
Apresentação Oral - Trabalho 45 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 45 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 45 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 45 (19/09/2012 - Tarde)
 
Apresentação Oral - Trabalho 46 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 46 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 46 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 46 (19/09/2012 - Tarde)
 
Apresentação Oral - Trabalho 88 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 88 (19/09/2012 - Tarde)Apresentação Oral - Trabalho 88 (19/09/2012 - Tarde)
Apresentação Oral - Trabalho 88 (19/09/2012 - Tarde)
 
Curso enfermagem dermato.pediat. - 20/09/2012
Curso enfermagem dermato.pediat. - 20/09/2012Curso enfermagem dermato.pediat. - 20/09/2012
Curso enfermagem dermato.pediat. - 20/09/2012
 
Dra. lina - 20/09/2012
Dra. lina - 20/09/2012Dra. lina - 20/09/2012
Dra. lina - 20/09/2012
 
Dra. sandra gargur - 20/09/2012
Dra. sandra gargur - 20/09/2012Dra. sandra gargur - 20/09/2012
Dra. sandra gargur - 20/09/2012
 
Dra. silvana ferreira - 20/09/2012
Dra. silvana ferreira - 20/09/2012Dra. silvana ferreira - 20/09/2012
Dra. silvana ferreira - 20/09/2012
 
Dra. vania declair - 20/09/2012
Dra. vania declair - 20/09/2012Dra. vania declair - 20/09/2012
Dra. vania declair - 20/09/2012
 
Pedro dantas - 20/09/2012
Pedro dantas - 20/09/2012Pedro dantas - 20/09/2012
Pedro dantas - 20/09/2012
 
Quality care indicators - 20/09/2012
Quality care indicators - 20/09/2012Quality care indicators - 20/09/2012
Quality care indicators - 20/09/2012
 
Shirley - 20/09/2012
Shirley - 20/09/2012Shirley - 20/09/2012
Shirley - 20/09/2012
 

International Projects Prevent Chronic Wounds

  • 1. International Projects to Prevent Chronic Wounds Professor Carol Dealey
  • 2. In this presentation • I will be talking about 3 different international projects in which I have been involved as useful examples • They have all been undertaken in a slightly different way • They all involve pressure ulcers
  • 3. International Pressure Ulcer Guidelines • This project took over my life for 5 years! • It was very hard work, but very satisfying. • I made some good friends during this time • So – here is the story of how the guidelines were developed.
  • 4. The Two Societies . EPUAP = European Pressure Ulcer NPUAP = National Pressure Ulcer Advisory Panel, founded in 1996 it Advisory Panel and it is an is a Pan-European Society American society founded in 1987
  • 5. • Both associations had produced pressure ulcer guidelines: NPUAP in 1992 (Prevention) and 1994 (Treatment) EPUAP in 1997 (Prevention, 1998 (Treatment) and 2003 (Nutrition) There was an urgent need for these guidelines to be updated
  • 6. When in doubt – form a committee! • Guideline development Group (GDG)– from both EPUAP and NPUAP • Carol Dealey – Chair EPUAP GDG • Janet Cuddigan & Diane Langemo – Co-Chairs of NPUAP GDG • 5 members from each society
  • 7. Guideline Development Group European Pressure Ulcer Advisory Panel Dr. Carol Dealey Dr. Michael Clark, Dr. Lisette Schoonhoven, Anne Witherow, Prof. Dr. Tom Defloor, Dr. Katrien Vanderwee National Pressure Ulcer Advisory Panel Dr. Janet Cuddigan Dr. Diane K. Langemo Dr. Mona M. Baharestani Mary Ellen Posthauer Dr. Joyce Black Evan Call
  • 8. The full GDG (NPUAP and EPUAP) defined a search strategy for both guidelines. • Evidence was limited to papers published in peer-reviewed journals and cited on PubMed, CINAHL, EMBASE, AHMED or the Cochrane and HTA databases. Quantitative studies were included if they were laboratory-based studies, controlled or cohort studies. • The full GDG developed a template for all the evidence tables
  • 9. • The full GDG agreed the hierarchy of evidence to be used in both guidelines • Each guideline was divided into a series of topics, recognising that there will be some overlap between the two. • The treatment guideline does not include all possible topics, but has assessed those most clinically useful
  • 10. Strength of Evidence Rating for Strength of Evidence Recommendations • A – Recommendation supported by direct scientific evidence from properly designed & implemented controlled trials on PU in humans providing statistical results that consistently support the guideline statement. (Level I studies) • B – Recommendation supported by direct scientific evidence from properly designed & implemented clinical series on PU in humans providing statistical results that consistently support the recommendation. (Level II, III, IV, V studies) • C – The recommendation is supported by expert opinion or indirect evidence (e.g. surrogate outcomes, studies in animal models & other types of chronic wounds).
  • 11. Reviewing the Evidence Small Working Groups (SWGs) • Sub-groups, each with a sub-group leader, reviewed the literature for specific topics • Evidence tables were produced, allowing the SWG to develop guideline statements and a summary of the evidence • Guideline statements and supporting text sent to GDG for review
  • 12. Draft recommendations then circulated to full GDG (NPUAP and EPUAP) for comments • The GDG met to agree format for the guideline document and review the draft recommendations in order to develop the 1st draft of the guideline topics • The topics were then made available for stakeholder review
  • 13. 146 Representatives from 32 Countries
  • 14. And 903 individuals from 53 countries
  • 15. Review • Every stakeholder was informed when the statements were available for review and given the opportunity to comment on the statements both by suggesting literature that might have been missed and commenting on the text • The full GDG met to discuss each comment and review the suggested literature • The guideline text was then revised in the light of the literature/comments as appropriate
  • 16. Final Draft Stage • This stage was all about ensuring there were no anomalies between treatment and prevention • Checking the text for typos • Ensuring we had all the evidence tables • Checking and rechecking the references
  • 17. The Guidelines were published in 2009 They are available as a Clinical Practice Guide and as Quick Reference Guides The QRG is available in 18 different languages including Portuguese The translations are freely available for download at www.epuap.org
  • 18. What did I learn about International collaboration? • It is really important to talk to each other – emails are not enough! • When we started the guidelines the 2 societies did not know each other well and there were misunderstandings at first. American English and English English are not the same! • Be prepared to compromise
  • 20. A project to produce a consensus document on pressure ulcer aetiology. It aimed to expand on the information in the International Pressure Ulcer Guidelines. Unlike the Guidelines which were funded by EPUAP and NPUAP, this was funded by an unrestricted educational grant from KCI Europe Holding BV
  • 21. Expert working group • Mona Baharestani*, (USA) • Maarten Lubbers*, (The • Netherlands) Joyce Black*, (USA) • Courtney Lyder*, (USA) • Keryln Carville, (Australia) • Takehiko Ohura, (Japan) • Michael Clark*, (UK) • Heather Orsted, (Canada) • Janet Cuddigan*, (USA) • Vinoth Ranganathan, (USA) • Carol Dealey*, (UK) • Steven Reger*, (USA) • Tom Defloor*, (Belgium) • Marco Romanelli*, (Italy) • Amit Gefen*, (Israel) • Hiromi Sanada, (Japan) • Keith Harding, (UK) • Makoto Takahashi, (Japan) • Nils Lahmann*, Berlin (Germany) * = worked on EPUAP/NPUAP Guidelines
  • 22. Pressure, shear, friction and microclimate – why needed? • Pressure has long been viewed as the most important extrinsic factor in pressure ulcer development • Increasing interest in the roles of shear, friction and microclimate • Emerging awareness of the synergistic links between pressure, shear, friction and microclimate
  • 23. Pressure, shear, friction and microclimate Groundbreaking initiative: • Fulfilled a need for educational materials that aid understanding of the basic physics involved in pressure, shear, friction and microclimate • Demonstrated how the physics involved underpins best clinical practice in the prevention (and treatment) of pressure ulcers
  • 24. Pressure, shear, friction and microclimate The technical section of each paper: • Defined the relevant extrinsic factor • Clearly described basic physics involved • Explained the contribution of the extrinsic factor to pressure ulcer aetiology • Described the links between the factors
  • 25. Pressure, shear, friction and microclimate The clinical practice section of each paper: • Described how to identify patients at risk from the extrinsic factor • Explained the types of and rationale for the clinical interventions that aim to prevent or ameliorate the effects of the extrinsic factor Note: Pressure ulcer prevention involves much more than extrinsic factor modification: this document was not intended to provide a comprehensive discussion of pressure ulcer prevention protocols
  • 26. How did this project work? • This work was undertaken with a mixture of teleconferences and emails • The scientists wrote the physics part and some of the clinicians (mostly nurses) wrote the clinical application • It went out for review to the rest of the expert group
  • 27. The Outcome A useful document freely available to download from the Wounds International website: http://www.woundsinte rnational.com/pdf/cont ent_8925.pdf
  • 28. What did I learn from this project? • We need scientists to explain the physics • But they cannot apply this knowledge to clinical practice – that is where nurses come in. • So we need multi-professional working – and to respect each others’ expertise
  • 29. There’s more • When you know each other it is easier to work at long distance • This project involved writing, reviewing and judicious editing and formatting (by Wounds International) • There did not need to be a lot of debate on the content
  • 31. Global Evidence Based Practice Recommendations for the Use of Wound Dressings to Augment Pressure Ulcer Prevention Protocols - August 2012 This is very new and not totally completed, so I am going to tell you quite a bit about it It has been funded by an educational grant from Molnlycke Healthcare
  • 32. Consensus group Joyce Black RN PhD Michael Clark PhD Paulo Alves RN MSc Tod Brindle RN MSc (Co-Chair) (Co-Chair) Paulo Alves is an Assistant Professor Tod Brindle is a wound and ostomy Dr Black is an Associate Professor of Dr Clark is a Visiting Professor in of Nursing and Tissue Viability at the consultant for the Virginia Nursing at the University of Nebraska Tissue Viability, Birmingham City Catholic University of Portugal and Commonweath University Medical in the USA. She is a Fellow of the US University, UK and Manager of the researcher of the Portuguese Wound Center, Richmond, in the USA. His Academy of Nursing and currently on Welsh Wound Network. He is also Management Association. Pressure clinical specialty area includes the Board of the National Pressure President of the European Pressure Ulcers are his main research. He is pressure ulcer prevention in high risk Ulcer Advisory Panel. Ulcer Advisory Panel currently a board member of the populations. European Pressure Ulcer Advisory Panel and the European Wound Management Association. Evan Call MS, CSM (NRM) Carol Dealey RN PhD Nick Santamaria RN PhD Evan Call is Adjunct Faculty in the Dr Dealey is Senior Research Fellow Dr Santamaria is Professor of Microbiology Department at Weber at University Hospital Birmingham Nursing Research, Translational State University, USA, and NHS Foundation Trust and Honorary Research at The University of undertakes research in relation to Professor in Tissue Viability at Melbourne and The Royal Melbourne medical devices for pressure ulcer University of Birmingham in the UK. Hospital, Australia. His research prevention. He is currently on the Her main research programme is the involves the prevention of pressure Board of the National Pressure Ulcer prevention of pressure ulcers. She is ulcers in critically ill trauma patients Advisory Panel. a Past President of the European in ICU. Pressure Ulcer Advisory Panel.
  • 33. What have we been doing? 1. A literature review of current evidence which included both clinical and laboratory studies relating to the use of dressings for pressure ulcer prevention 2. This improved our understanding of their role in reducing the impact of pressure, shear and microclimate 3. This information provided the evidence we needed to develop Best Practice Statements of the likely effectiveness of dressing when used in pressure ulcer prevention alongside other prevention methods. These statements were presented at the WUWHS Conference in Japan in a Quick Reference Guide 4. We are planning a full document with all the evidence to be submitted for publication in a wound journal
  • 34. • So what do dressings do in pressure ulcer prevention?
  • 35. Shear redistribution The dressing translates shear force to the skin outside the area of concern. Without a dressing Within the dressing the interface of multiple layers aids in the absorption of shear
  • 36. Friction reduction If the surface of the dressing is slippery Without a dressing it will reduce friction, conversely if it is not it will increase friction.
  • 37. Pressure • redistribution Without a dressing A dressing with adequate thickness distributes forces over a larger area thus accomplishing pressure re-distribution
  • 38. Balance of Skin Microclimate With a basic dressing With a multi layer silicone foam dressing
  • 39. Balance of Microclimate A dressing that maintains relative humidity of between 40 and 80% at the skin surface helps maximise the resilience of the skin. Dressings that trap moisture at the skin surface reduce the strength of the skin and lead to maceration. Dressings that withdraw too much moisture can predispose skin to stiffness and cracking. This can be identified by obvious signs of maceration or dryness.
  • 40. Do some dressings outperform others? • Laboratory tests found a multilayer silicone dressing out- performed others • But need clinical confirmation – there are some cohort studies + awaiting the results of an Australian RCT
  • 41. In the meantime…. Based on what we know so far we have produced a dressing selection guide
  • 42. Part of the Dressing Selection Guide for Pressure Ulcer Prevention in the Sacrum and Buttocks Mechanism of Injury Mechanisms of Dressing Selection Pressure, Friction, Protection Shear & Microclimate Elevating the head of the The dressings used for Structure: bed increases pressure and pressure ulcer prevention shear on the pelvic region, should: A multi layer silicone foam note the percent of body 1. Redistribute pressure dressing mass that is focused on the 2. Minimise shear with the ability to redistribute pelvic region as the head of 3. Balance micro-climate pressure, redistribute and bed is raised. 4. Reduce friction absorb shear, and 0° = 30% of body mass 5. Prevent mechanical effectively manage 30° = 44% of body mass stripping of skin when microclimate. 45° = 52% of body mass removing the dressing to 90° = 70% of body mass inspect the skin 6. Provide barrier protection to the skin 7. Have an atraumatic contact layer
  • 43. You can get a copy From the Neve Stand in the Exhibition
  • 44. So what have I learnt from this project? • We had an initial meeting followed by teleconferences. This worked when we were assembling the evidence. • It did not work for writing the Best Practice Statements and we ended up meeting for 2 days to write them • Meetings are essential for writing guidelines or best practice statements
  • 45. Overall Conclusions • It is good to work with colleagues from other countries – people are the same everywhere, we just need to get better at talking to each other • Nurses can make an important contribution – but we need to work in multi-professional groups in order to produce really significant outcomes